1477 related articles for article (PubMed ID: 9863360)
1. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
2. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes.
Stevanin G; Fujigasaki H; Lebre AS; Camuzat A; Jeannequin C; Dode C; Takahashi J; San C; Bellance R; Brice A; Durr A
Brain; 2003 Jul; 126(Pt 7):1599-603. PubMed ID: 12805114
[TBL] [Abstract][Full Text] [Related]
3. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.
Kremer B; Goldberg P; Andrew SE; Theilmann J; Telenius H; Zeisler J; Squitieri F; Lin B; Bassett A; Almqvist E
N Engl J Med; 1994 May; 330(20):1401-6. PubMed ID: 8159192
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of trinucleotide repeat expansion as a new mechanism of mutation in Huntington's chorea: theoretical and applied aspects].
Illarioshkin SN; Ivanova-Smolenskaia IA; Markova ED; Nikol'skaia NN; Chabrashvili TZ; Insarova NG
Genetika; 1996 Jan; 32(1):103-9. PubMed ID: 8647411
[TBL] [Abstract][Full Text] [Related]
5. [Huntington chorea: (CAG)n repeats on gene IT 15 in Austria].
Meszaros K; Willinger U; Heiden AM; Fuchs K; Baumhackl U; Brücke T; Feucht M; Fathi N; Lenzinger E; Miller E
Wien Klin Wochenschr; 1994; 106(21):671-2. PubMed ID: 7810152
[TBL] [Abstract][Full Text] [Related]
6. CAG mutation effect on rate of progression in Huntington's disease.
Squitieri F; Cannella M; Simonelli M
Neurol Sci; 2002 Sep; 23 Suppl 2():S107-8. PubMed ID: 12548366
[TBL] [Abstract][Full Text] [Related]
7. Trinucleotide repeat length and rate of progression of Huntington's disease.
Illarioshkin SN; Igarashi S; Onodera O; Markova ED; Nikolskaya NN; Tanaka H; Chabrashwili TZ; Insarova NG; Endo K; Ivanova-Smolenskaya IA
Ann Neurol; 1994 Oct; 36(4):630-5. PubMed ID: 7944295
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the Huntington's disease gene in New Zealand.
Whitefield JE; Williams L; Snow K; Dixon J; Winship I; Stapleton PM; Faull RM; Love DR
N Z Med J; 1996 Feb; 109(1015):27-30. PubMed ID: 8606810
[TBL] [Abstract][Full Text] [Related]
9. [Huntington's chorea: clinical aspects, genetics and current diagnosis].
Spiegel R
Ther Umsch; 1995 Dec; 52(12):814-20. PubMed ID: 8539653
[TBL] [Abstract][Full Text] [Related]
10. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.
Snell RG; MacMillan JC; Cheadle JP; Fenton I; Lazarou LP; Davies P; MacDonald ME; Gusella JF; Harper PS; Shaw DJ
Nat Genet; 1993 Aug; 4(4):393-7. PubMed ID: 8401588
[TBL] [Abstract][Full Text] [Related]
11. Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease.
Finke K; Bublak P; Dose M; Müller HJ; Schneider WX
Brain; 2006 May; 129(Pt 5):1137-51. PubMed ID: 16504973
[TBL] [Abstract][Full Text] [Related]
12. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
[TBL] [Abstract][Full Text] [Related]
13. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
[TBL] [Abstract][Full Text] [Related]
14. [Expansion of triplet repeat and neurodegenerative disorders].
Kanazawa I
Rinsho Shinkeigaku; 1994 Dec; 34(12):1224-6. PubMed ID: 7774118
[TBL] [Abstract][Full Text] [Related]
15. CAG repeat number governs the development rate of pathology in Huntington's disease.
Penney JB; Vonsattel JP; MacDonald ME; Gusella JF; Myers RH
Ann Neurol; 1997 May; 41(5):689-92. PubMed ID: 9153534
[TBL] [Abstract][Full Text] [Related]
16. [The gene responsible for Huntington's disease in Spanish families: its diagnostic value and the relation between trinucleotide expansion and the clinical characteristics].
Benítez J; Fernández E; García Ruiz P; Robledo M; Ayuso C; García Yébenes J
Rev Clin Esp; 1994 Aug; 194(8):591-3. PubMed ID: 7938836
[TBL] [Abstract][Full Text] [Related]
17. The relationship between CAG repeat length and clinical progression in Huntington's disease.
Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
[TBL] [Abstract][Full Text] [Related]
18. Effect of CAG repeat length on psychiatric disorders in Huntington's disease.
Vassos E; Panas M; Kladi A; Vassilopoulos D
J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899
[TBL] [Abstract][Full Text] [Related]
19. [Molecular genetics of Huntington's disease].
Goto J; Masuda N; Watanabe M; Kanazawa I
Rinsho Shinkeigaku; 1995 Dec; 35(12):1529-31. PubMed ID: 8752453
[TBL] [Abstract][Full Text] [Related]
20. Issues in Huntington's disease testing.
Rubinsztein DC; Barton DE; Ferguson-Smith MA
Q J Med; 1994 Feb; 87(2):71-3. PubMed ID: 8153290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
